Clinical Trials Logo
  1. Home
  2. Breast Cancer
  3. NCT04688762
  4. Details
NCT04688762 Clinical Trial

The E-consult Application for Patients With Breast Cancer: Interest in Empathy and Empowerment of Patients.

Breast Cancer Clinical Trial

— e-CONSULT  

Official title:
The E-consult Application for Patients With Breast Cancer: Interest in Empathy and Empowerment of Patients.

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04688762
Other study ID # 2020-A02045-34
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 24, 2020
Est. completion date November 16, 2022

Study information
Verified date December 2022
Source Centre Francois Baclesse
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Demonstrate that the use of this application in consultation could improve the empathy perceived of the doctors by the patients after the consultation.

Recruitment information / eligibility
Status Completed
Enrollment 206
Est. completion date November 16, 2022
Est. primary completion date November 16, 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient > 18 years old - Patient referred for first consultation for surgery - Patient referred for a breast tumorectomy and axillary sentinel node - No patient opposition to participating in this study Exclusion Criteria: - Non-surgical management - Management by any surgery other than breast tumorectomy and axillary sentinel node - Any associated medical, social or psychopathological condition that could compromise the patient's ability to participate in the study - Patient deprived of liberty or under guardianship - Person subject to legal protection or unable to express their consent

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• e-consult application (tool)
A numeric application used as a support in consultation to explain the surgical management of the patient.

Locations
Country Name City State
France Centre François Baclesse Caen

Sponsors (1)
Lead Sponsor Collaborator
Centre Francois Baclesse

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Demonstrate that the use of this application in consultation could improve the empathy perceived of the doctors by the patients after the consultation. The average obtained in the CARE questionnaire by patients (score [10-50]) before surgery
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A